These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 18166258)

  • 21. Aripiprazole. The newest antipsychotic agent for treatment of schizophrenia.
    Bailey KP
    J Psychosoc Nurs Ment Health Serv; 2003 Feb; 41(2):14-8. PubMed ID: 12613095
    [No Abstract]   [Full Text] [Related]  

  • 22. An open randomized pilot trial on the differential effects of aripiprazole versus risperidone on anhedonia and subjective well-being.
    Liemburg E; Aleman A; Bous J; Hollander K; Knegtering H
    Pharmacopsychiatry; 2011 May; 44(3):109-13. PubMed ID: 21432752
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Reversal of antipsychotic-induced hyperprolactinemia, weight gain, and dyslipidemia by aripiprazole: A case report.
    Lin SK; Chen CK
    J Clin Psychiatry; 2006 Aug; 67(8):1307. PubMed ID: 16965214
    [No Abstract]   [Full Text] [Related]  

  • 24. Use of Aripiprazole in treatment resistant schizophrenia.
    Hughes D; Morcos M
    J Psychopharmacol; 2008 Nov; 22(8):927-8. PubMed ID: 18308805
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Persistent hiccups associated with switching from risperidone to aripiprazole in a schizophrenic patient with cerebral palsy.
    Yeh YW
    Clin Neuropharmacol; 2011; 34(4):135-6. PubMed ID: 21768798
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Aripiprazole in chronic schizophrenia: experiences in daily practice.
    Fernald DS; van Dellen RT; Hovens JE; Loonen AJ
    Acta Psychiatr Scand; 2006 Oct; 114(4):294; author reply 294. PubMed ID: 16968370
    [No Abstract]   [Full Text] [Related]  

  • 27. Time course of the changes in antipsychotic-induced hyperprolactinemia following the switch to aripiprazole.
    Lu ML; Shen WW; Chen CH
    Prog Neuropsychopharmacol Biol Psychiatry; 2008 Dec; 32(8):1978-81. PubMed ID: 18848860
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Granulomatous cutaneous lesions associated with risperidone-induced hyperprolactinemia in an amputated upper limb.
    Lin CH; Ma H; Chung MT; Chou J
    Int J Dermatol; 2012 Jan; 51(1):75-8. PubMed ID: 21834946
    [No Abstract]   [Full Text] [Related]  

  • 29. Combined use of ECT with aripiprazole.
    Lopez-Garcia P; Chiclana C; Gonzalez R
    World J Biol Psychiatry; 2009; 10(4 Pt 3):942-3. PubMed ID: 17853257
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clozapine augmented with aripiprazole in 5 patients with schizophrenia.
    Abu-Tair F; Kopitz J; Bergemann N
    J Clin Psychopharmacol; 2006 Dec; 26(6):669-71. PubMed ID: 17110831
    [No Abstract]   [Full Text] [Related]  

  • 31. Effectiveness of intramuscular aripiprazole injection in patients with catatonia: report on three cases.
    Voros V; Kovacs A; Herold R; Osvath P; Simon M; Fekete S; Tenyi T
    Pharmacopsychiatry; 2009 Nov; 42(6):286-7. PubMed ID: 19924590
    [No Abstract]   [Full Text] [Related]  

  • 32. No better solution for antipsychotic treatment with regard to long-term safety and effectiveness.
    Lai EC; Yang YH
    Evid Based Ment Health; 2015 Feb; 18(1):17. PubMed ID: 25239248
    [No Abstract]   [Full Text] [Related]  

  • 33. Perinatal use of aripiprazole: a case report.
    Watanabe N; Kasahara M; Sugibayashi R; Nakamura T; Nakajima K; Watanabe O; Murashima A
    J Clin Psychopharmacol; 2011 Jun; 31(3):377-9. PubMed ID: 21532364
    [No Abstract]   [Full Text] [Related]  

  • 34. Use of aripiprazole in tardive dyskinesia: an open label study of six cases.
    Rajarethinam R; Dziuba J; Manji S; Pizzuti A; Lachover L; Keshavan M
    World J Biol Psychiatry; 2009; 10(4 Pt 2):416-9. PubMed ID: 19492247
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The use of aripiprazole in early onset schizophrenia: safety and efficacy.
    Normala I; Hamidin A
    Med J Malaysia; 2009 Sep; 64(3):240-1. PubMed ID: 20527278
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Aripiprazole: a review of its pharmacology and clinical use.
    Taylor DM
    Int J Clin Pract; 2003; 57(1):49-54. PubMed ID: 12587943
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Aripiprazole resolves symptomatic hyperprolactinemia in a male schizophrenic patient.
    Chen CH; Huang MC; Lu ML
    Prog Neuropsychopharmacol Biol Psychiatry; 2008 Apr; 32(3):893-4. PubMed ID: 18082301
    [No Abstract]   [Full Text] [Related]  

  • 38. Comparing tolerability profile of quetiapine, risperidone, aripiprazole and ziprasidone in schizophrenia and affective disorders: a meta-analysis.
    Moteshafi H; Stip E
    Expert Opin Drug Saf; 2012 Sep; 11(5):713-32. PubMed ID: 22913713
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Aripiprazole: a new atypical antipsychotic with a different pharmacological mechanism.
    Naber D; Lambert M
    Prog Neuropsychopharmacol Biol Psychiatry; 2004 Dec; 28(8):1213-9. PubMed ID: 15588748
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Serotonin(1A) receptors in the action of aripiprazole.
    Sumiyoshi T
    J Clin Psychopharmacol; 2014 Jun; 34(3):396-7. PubMed ID: 24717255
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.